Two Catalysts For Axovant Sciences In March
Two Catalysts For Axovant Sciences In March.....»»
Upcoming Catalysts Make Axovant Attractive, Jefferies Says In Upgrade
Axovant Sciences Ltd (.....»»
Earnings Scheduled For March 10, 2021
Companies Reporting Before The Bell • BioDelivery Sciences Intl (NASDAQ:BDSI) is estimated t.....»»
Why Cassava Shares Are Rallying Today
Cassava Sciences Inc (NASDAQ: SAVA) shares were trading solidly higher Monday on above-average volume in reaction to updates from the company on clinical programs and upcoming catalysts. read more.....»»
Lilly Awash In Catalysts, Pipeline Updates, Mizuho Says In Upgrade
Eli Lilly And Co (NYSE: LLY) received an upgrade from a Mizuho Securities analyst ahead of a key data readout in March. The Lilly Analyst: Vamil Divan upgraded Lilly shares from Neutral to Buy and increased the price target from $164 to $222.....»»
Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update
Net working capital of $36.4 Million CAD at December 31, 2019 On March 20, 2020 Khiron became the first and only company in Colomb.....»»
Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update
Net working capital of $36.4 Million CAD at December 31, 2019 On March 20, 2020 Khiron became the first and only company in Colombia to receive full authorization to manufactu.....»»
Senseonics receives millions from PPP, increases borrowing amid strategic review of business
The Maryland life sciences company halted domestic commercial sales and announced a possible sale of the business at the end of March......»»
Strata Skin Sciences says March gross procedure revenue declined 17% y-o-y
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Tauriga Sciences, Inc. Reports Continued Surge in its E-Commerce Business Segment
On Sunday March 29, 2020 - The Company Set New Daily Records fo.....»»
Zyla Life Sciences Reports Fourth Quarter and Full Year 2019 Financial Results
WAYNE, Pa., March 27.....»»
The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA) Centogene NV (NASDAQ: CNTG) Gilead Sciences, Inc. (NA.....»»
Kodiak Sciences Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
PALO ALTO, Calif., March 16, 2020 /PRNewswire/ --Â Kodiak Sciences Inc. (NASDAQ:KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalen.....»»
UCF narrows the field of presidential job candidates to 3
The University of Central Florida presidential search committee on March 5 narrowed the field to three job candidates. The three to advance in the search process are: David Brenner, vice chancellor of health sciences at the University of Californ.....»»
First Week of March 20th Options Trading For Anavex Life Sciences (AVXL)
Stock Options Channel.....»»
Axovant Sciences price target raised to $32 from $28 at JMP Securities
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
CV Sciences, Charlotte"s Web offer most upside on CBD catalysts, says Piper
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Three Q4"19 Catalysts For Axovant
Three Q4"19 Catalysts For Axovant.....»»
Will Axovant Sciences Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor Axovant Sciences. Want the latest recommendations from Zack.....»»
Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019
-Announced positive Phase 3 results from LIBERTY 1 study evaluating relugolix combination therapy in women with uterine fibroids- -Data from four additional Phase 3 clinical studies ex.....»»
BioDelivery Sciences International, Inc. (BDSI) Q1 2019 Earnings Call Transcript
BDSI earnings call for the period ending March 31, 2019......»»